Co-Authors
This is a "connection" page, showing publications co-authored by Keith Jerome and Anna Wald.
Connection Strength
0.232
-
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. EClinicalMedicine. 2021 Mar; 33:100773.
Score: 0.058
-
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19. Sci Rep. 2021 02 22; 11(1):4290.
Score: 0.058
-
Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates. J Clin Invest. 2021 02 01; 131(3).
Score: 0.058
-
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial. Ann Intern Med. 2021 03; 174(3):344-352.
Score: 0.057